Paper40176397
Metabolic Consequences of Rheumatoid Arthritis.
Barry S and 2 others. Arthritis Care Res (Hoboken), 2025. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Metabolic Consequences of Rheumatoid Arthritis. Papers, record 40176397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40176397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Humans | |
| Insulin Resistance | |
| Metabolic Syndrome | |
| Body Composition | |
| Blood Pressure |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| I01 RX003644 | RRD VA | United States | I01RX003644 | PubMed and NIH | NIH RePORTER |
| I01 RX004770 | RRD VA | United States | I01RX004770 | PubMed and NIH | NIH RePORTER |
| R01 AR083584 | NIAMS NIH HHS | United States | R01AR083584 | PubMed and NIH | NIH RePORTER |
| R01-AR083584 | NIAMS NIH HHS | United States | R01AR083584 | PubMed and NIH | NIH RePORTER |
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27338263 | Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases. | Arthritis Res Ther | 2016 | https://conductscience.org/library/papers/27338263 | PubMed |
| 2 | 38216757 | Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. | Nat Rev Rheumatol | 2024 | https://conductscience.org/library/papers/38216757 | PubMed |
| 3 | 23950188 | Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. | J Rheumatol | 2013 | https://conductscience.org/library/papers/23950188 | PubMed |
| 4 | 28845751 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28845751 | PubMed |
| 5 | 27079757 | Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist. | Semin Arthritis Rheum | 2016 | https://conductscience.org/library/papers/27079757 | PubMed |
| 6 | 29544870 | Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29544870 | PubMed |
| 7 | 33666156 | Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial. | Clin Exp Rheumatol | 2021 | https://conductscience.org/library/papers/33666156 | PubMed |
| 8 | 25303044 | Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. | Arthritis Rheumatol | 2015 | https://conductscience.org/library/papers/25303044 | PubMed |
| 9 | 31513665 | Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial. | PLoS Med | 2019 | https://conductscience.org/library/papers/31513665 | PubMed |
| 10 | 35366608 | Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis. | J Autoimmun | 2022 | https://conductscience.org/library/papers/35366608 | PubMed |
| 11 | 33771189 | Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis. | Arthritis Res Ther | 2021 | https://conductscience.org/library/papers/33771189 | PubMed |
| 12 | 37453736 | Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib. | J Rheumatol | 2023 | https://conductscience.org/library/papers/37453736 | PubMed |
| 13 | 31721697 | Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age. | Curr Pharm Des | 2019 | https://conductscience.org/library/papers/31721697 | PubMed |
| 14 | 36450449 | Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. | Ann Rheum Dis | 2023 | https://conductscience.org/library/papers/36450449 | PubMed |
| 15 | 20589684 | Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20589684 | PubMed |
| 16 | 33397733 | Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis. | Ann Rheum Dis | 2021 | https://conductscience.org/library/papers/33397733 | PubMed |
| 17 | 27697765 | EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. | Ann Rheum Dis | 2017 | https://conductscience.org/library/papers/27697765 | PubMed |
| 18 | 35021057 | Inflammation in obesity, diabetes, and related disorders. | Immunity | 2022 | https://conductscience.org/library/papers/35021057 | PubMed |
| 19 | 25535750 | Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. | Clin Exp Rheumatol | 2015 | https://conductscience.org/library/papers/25535750 | PubMed |
| 20 | 32907617 | Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials. | Arthritis Res Ther | 2020 | https://conductscience.org/library/papers/32907617 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953051 | Gut microbiota and intestinal permeability in rheumatoid arthritis: therapeutic implications and future directions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42953051 | PubMed |
| 42688426 | Factors associated with concurrent cardiovascular disease in patients with rheumatoid arthritis and development of machine learning models for comorbidity identification. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42688426 | PubMed |
| 42609198 | Bibliometric analysis of research on sarcopenia in rheumatoid arthritis: 1997-2025. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42609198 | PubMed |
| 42602085 | Neutrophil percentage-to-albumin ratio is associated with low muscle mass risk in rheumatoid arthritis: evidence from a hospital-based cohort and NHANES validation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42602085 | PubMed |
| 42589137 | Lipid Immunometabolism in Autoimmune Rheumatic Diseases: Mechanistic Links Between Chronic Inflammation, Lipoprotein Dysfunction and Cardiovascular Risk. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42589137 | PubMed |
| 42558807 | Manual dexterity and plaque accumulation in patients with rheumatoid arthritis. | Front Oral Health | 2026 | https://conductscience.org/library/papers/42558807 | PubMed |
| 42470822 | Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42470822 | PubMed |
| 42072621 | The N6-Methyladenosine RNA Demethylase AlkB Homolog 5 (ALKBH5) in Metabolic Diseases: Molecular Mechanisms and Pharmacological Implications-A Review. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072621 | PubMed |
| 41754190 | Nutritional Risk in Older Adults with Rheumatoid Arthritis: Sex-Specific Patterns and Clinical Implications of the Prognostic Nutritional Index. | Nutrients | 2026 | https://conductscience.org/library/papers/41754190 | PubMed |
| 41459480 | Integrated analysis of the relationship between metabolic pathways and immune infiltration in rheumatoid arthritis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459480 | PubMed |
| 41007860 | A Potential Role of Adropin in Inflammatory Rheumatic Diseases-What Do We Know So Far? | Biomedicines | 2025 | https://conductscience.org/library/papers/41007860 | PubMed |
| 40802417 | Polypharmacy and drug interactions in the management of rheumatoid arthritis. | Rev Assoc Med Bras (1992) | 2025 | https://conductscience.org/library/papers/40802417 | PubMed |
| 40565171 | Endocannabinoid Tone and Oxylipins in Rheumatoid Arthritis and Osteoarthritis-A Novel Target for the Treatment of Pain and Inflammation? | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565171 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40176397
GET https://conductscience.org/api/papers/v1/40176397/references?page=2